Ever Supreme (6712.TWO) monthly revenue, September 2026
Ever Supreme reported revenue of NT$0.11bn for September 2026, up 0.8% from the previous month and up 21.3% from a year earlier. Year-to-date revenue was NT$0.78bn, up 17.6% year on year. It ranked 53 of 159 companies in the Biotechnology and Medical Care industry by year-on-year growth.
| Month | Revenue NT$bn | MoM % | YoY % |
|---|---|---|---|
| September 2026 | 0.11 | 0.8 | 21.3 |